Evidence map›Paper›PMID 26948708›Full record

ArticleNeuromuscular disorders : NMD2016

212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015.

M Saunier, C G Bönnemann, M Durbeej, V Allamand, CMD Animal Model Consortium

Abstract readConference Proceedings
In one paragraph

Article in Neuromuscular disorders : NMD, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Mouse models for muscular dystrophies: an overview.Disease models & mechanisms · 2020
    Review
  2. Zebrafish Models ofFrontiers in molecular neuroscience · 2020
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M SaunierUPMC Univ Paris 06, Inserm UMRS974, CNRS FRE3617, Center for Research in Myology, Institut de Myologie, GH Pitié-Salpêtrière, Sorbonne Universités, F-75013 Paris, France.
C G BönnemannNational Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD, USA.
M DurbeejDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
V AllamandUPMC Univ Paris 06, Inserm UMRS974, CNRS FRE3617, Center for Research in Myology, Institut de Myologie, GH Pitié-Salpêtrière, Sorbonne Universités, F-75013 Paris, France. Electronic address: v.allamand@institut-myologie.org.
CMD Animal Model Consortium

Funding

Molecular and Clinical Manifestations of Matrix and Aggregate MyopathiesZIANS003129 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BÖNNEMANN, CARSTEN · 2011 to 2025
$52.8M
Therapeutic Potential of ESC-Derived Myogenic PrecursorsU54NS053672 · NINDS · UNIVERSITY OF IOWA · PI MATHEWS, KATHERINE DIANNE · 2005 to 2019
$22.0M
Laminin protein therapy for Congenital Muscular DystrophyR01AR064338 · NIAMS · UNIVERSITY OF NEVADA RENO · PI BURKIN, DEAN J. · 2014 to 2018
$1.6M
Intramural NIH HHS Z99 NS999999Intramural NIH HHS ZIA NS003129NIAMS NIH HHS R01 AR064338NIAMS NIH HHS R01AR064338-01A1NINDS NIH HHS U54 NS053672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease Models, AnimalAnimalsCollagen Type VIHumansLamininMiceMice, TransgenicMuscular DystrophiesMuscular Dystrophy, AnimalNetherlandsWalker-Warburg SyndromeCol6a1 protein, humanCollagen Type VILamininlaminin alpha 2

Identifiers

PMID26948708
PMCPMC5210215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.